MaiLi Extreme with Lidocaine (4 x 1 ml)

MaiLi

Medical device – dermal filler

Cross-linked hyaluronic acid (HA) volumizing filler

CE Marked medical device (CE 2797) under European regulations for hyaluronic acid dermal fillers.
Manufactured according to quality and safety standards required for injectable HA fillers and in compliance with relevant medical device directives.
Supported by clinical data demonstrating efficacy and safety, including documented volume restoration, injectability characteristics and patient satisfaction in randomized controlled studies.

CE Marked medical device (CE 2797) under European regulations for hyaluronic acid dermal fillers.
Manufactured according to quality and safety standards required for injectable HA fillers and in compliance with relevant medical device directives.
Supported by clinical data demonstrating efficacy and safety, including documented volume restoration, injectability characteristics and patient satisfaction in randomized controlled studies.

Cross-linked hyaluronic acid (HA) volumizing filler

Description

MaiLi Extreme with Lidocaine (4 x 1 ml) is the most powerful dermal filler in the MaiLi range by Sinclair Pharma, formulated using patented OxiFree™ technology. The filler contains high-concentration cross-linked hyaluronic acid and lidocaine to provide powerful volumizing, sculpting, and profile-balancing effects while preserving natural facial movement and expression. Supplied as four 1 ml pre-filled syringes (each with needle), MaiLi Extreme is intended for deep volumetric enhancement of facial structures — for example cheeks, chin, jawline — as well as for reconstruction in cases of volume loss (e.g. lipoatrophy). The gel’s spring-like elasticity and high projection power allow for restoration or creation of facial volume with fewer syringes compared to some alternative HA fillers.

Bnefits

High volumizing power — ideal for cheeks, chin, jawline and overall profile balancing.
Strong projection capability enabling sculpting, contouring and deep volume restoration.
Long-lasting results: many patients experience up to 12 months of effect (sometimes longer) depending on area and individual metabolism.
Contains lidocaine (3 mg/ml) to improve injection comfort and reduce treatment-related pain.
OxiFree™ technology preserves long HA molecular chains — producing a supple, elastic gel that moves naturally with facial expression and reduces stiffness.
Requires less volume compared to some traditional HA fillers for similar outcomes — improves cost-effectiveness and reduces overfilling risk.

Indications

Sculpting and defining facial contours — cheeks, chin, jawline, and overall profile balancing.
Restoration or augmentation of facial volume lost due to aging, lipoatrophy (e.g. HIV-associated) or weight loss.
Facial reconstruction of structural defects or volume deficits from congenital, medical or traumatic origin.
Deep volumetric enhancement for patients seeking more pronounced facial reshaping or definition.
General aesthetic facial rejuvenation in areas requiring significant projection and structural support.